Risk of Death With Atypical Antipsychotic Drug Treatment for Dementia, Meta-analysis of Randomized Placebo-Controlled Trials
JAMA 294:1934-1943,1963, Schneider,L.S.,et al, 2005
Delayed Neurotoxicity in Primary Central Nervous System Lymphoma
Arch Neurol 62:1595-1600, Omuro,A.M.P.,et al, 2005
Oligophrenin 1 Mutations Frequently Cause X-Linked Mental Retardation with Cerebellar Hypoplasia
Neurol 65:1364-1369,1346, Zanni,G.,et al, 2005
Statins and Cognitive Functioning the Elderly
Neurol 65:1388-1394, Bernick,C.,et al, 2005
Clinicopath Conf., MELAS Syndrome
NEJM 353:2271-2280, Case 36-2005, 2005
Global Prevalence of Dementia: A Delphi Consensus Study
Lancet 366:2112-2117, Ferri,C.P.,et al, 2005
Neurologic and Developmental Disability at Six Years of Age After Extremely Preterm Birth
NEJM 352:9-19, 71, Marlow,N.,et al, 2005
Update on Primary Central Nervous System Lymphoma
Curr Opin Neurol 18:645-653, Plotkin,S.R., 2005
Arachnoid Cysts Cause Cognitive Deficits That Improve After Surgery
Neurol 64;160-162, Raeder,M.B.,et al, 2005
Migraine and Cerebral White Matter Lesions
The Neurologist 11:19-29, Gladstone,J.P. &Dodick,D.W., 2005
Bone Mineral Density and the Risk of Alzheimer Disease
Arch Neurol 62:107-111, Tan,Z.S.,et al, 2005
A 32-Year Prospective Study of Change in Body Weight and Incident Dementia
Arch Neurol 62:55-60,20, Stewart,R.,et al, 2005
Phenytoin Exposure Is Associated With Functional and Cognitive Disability After Subarachnoid Hemorrhage
Stroke 36:583-587, Naidech,A., et al, 2005
Unawareness of Cognitive Deficit (Cognitive Anosognosia) in Probable AD and Control Subjects
Neurol 64:693-699, Barrett, A.M., et al, 2005
Steroid Dementia: an Overlooked Diagnosis?
Neurol 64:707-709, Sacks,O. & Shulman,M., 2005
Specialist Palliative Care in Dementia
BMJ 330:57-58, Chen,F. & Majeed,A., 2005
Effects of Topiramate and Gabapentin on Cognitive Abilities in Healthy Volunteers
Neurol 64:792-798, Salinsky, M.D., et al, 2005
Recent Developments in Pain in Dementia
BMJ 330:461-464, Scherder,E., et al, 2005
Atypical Antipsychotic Drugs and Risk of Ischaemic Stroke: Population Based Retrospective Cohort Study
BMJ 330:445-448, Gill,S.S., et al, 2005
Neuropsychological Effects of Exposure to Anticonvulsant Medication in Utero
Neurol 64:949-954, 938, Vinten,J., et al, 2005
Normal Intelligence in Children with Prenatal Exposure to Carbamazepine
Neurol 62:28-32,8, Gaily,E.,et al, 2004
Transmissible Spongiform Encephalopathies
Lancet 363:51-61, Collins,S.J.,et al, 2004
Treatment-Induced Leukoencephalopathy in Primary CNS Lymphoma,A Clinical and Autopsy Study
Neurol 62:451-456, Lai,R.,et al, 2004
Bovine Spongiform Encephalopathy in the United States - An Epidemiologist's View
NEJM 350:539-542, Donnelly,C.A., 2004
Penetrance of the Fragile X-Associated Tremor/Ataxia Syndrome in a Premutation Carrier Population
JAMA 291:460-469, Jacquemont,S.,et al, 2004
Whole Brain Diffusion Tensor Imaging in HIV-Associated Cognitive Impairment
AJNR 25:195-200,167, Ragin,A.B.,et al, 2004
Cognitive Functions in Survivors of Primary Central Nervous System Lymphoma
Neurol 62:548-555,532, Correa,D.D.,et al, 2004
Cognitive Status and Quality of Life After Treatment for Primary CNS Lymphoma
Neurol 62:544-547,532, Harder,H.,et al, 2004
Cognitive Side Effects of Antiepileptic Drugs in Children
Neurol 62:872-877, Loring,D.W.&Meador,K.J., 2004
Size of the Treatment Effect on Cognition of Cholinesterase Inhibition in Alzheimer's Disease
JNNP 75:677-685, Rockwood,K., 2004
Estimating Prognosis for Nursing Home Residents with Advanced Dementia
JAMA 291:2734-2740, Mitchell,S.L.,et al, 2004
Dementia After Stroke
Stroke 35:1264-1269, Ivan,C.S.,et al, 2004
Balint Syndrome Due to Creutzfeldt-Jakob Disease
Neurol 63:395, Ances,B.M.,et al, 2004
Atypical Antipsychotic Drugs in the Treatment of Behavioural and Psychological Symptoms of Dementia: Systematic Review
BMJ 329:75-78, Lee,P.E.,et al, 2004
Long-term Donepezil Treatment in 565 Patients with Alzheimer's Disease (AD2000): Randomised Double-Blind Trial
Lancet 363:2105-2115,2100, AD2000 Collaborative Group, 2004
Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women
JAMA 291:2947-2958,3005, Shumaker,S.A.,et al, 2004
Conjugated Equine Estrogens and Global Cognitive Function in Postmenopausal Women
JAMA 291:2959-2968,3005, Espeland,M.A.,et al, 2004
Most Cases of Dementia with Hippocampal Sclerosis May Represent Frontotemporal Dementia
Neurol 63:538-542, Hatanpaa,K.J.,et al, 2004
Diabetes, Impaired Fasting Glucose, and Development of Cognitive Impariment in Older Women
Neurol 63:658-663, Yaffe,K.,et al, 2004
Clinicopath Conf, Multiple-System Atrophy
NEJM 351:912-921, Case 27-2004, 2004
Progressive Dementia after First-Ever Stroke, A Community-Based Follow-up Study
Neurol 63:785-792, Srikanth,V.K.,et al, 2004
Higher Frequency of Dementia in Older HIV-1 Individuals, The Hawaii Aging with HIV-1 Cohort
Neurol 63:822-827, Valcour,V.,et al, 2004
Driver Route-Following and Safety Errors in Early Alzheimer Disease
Neurol 63:832-837, Uc,E.Y.,et al, 2004
Physical Activity, Including Walking, and Cognitive Function in Older Women
JAMA 292:1454-1461, Weuve,J.,et al, 2004
Walking and Dementia in Physically Capable Elderly Men
JAMA 292:1447-1453, Abbott,R.D.,et al, 2004
A Multimodal Assessment of Driving Performance in HIV Infection
Neurol 63:1417-1422, Marcotte,T.D.,et al, 2004
Progressive Posterior Cortical Dysfunction
Neurol 63:1175-1180, Renner,J.A.,et al, 2004
Clinical, Genetic, and Neuropathologic Characteristics of Posterior Cortical Atrophy
Neurol 63:1168-1174, Tang-Wai,D.F.,et al, 2004
The Shape of Things to Come
Neurol 63:948-950, Hauser,S.L., 2004
Slippery Slopes, Wonder Drugs, and Cosmetic Neurology
Neurol 63:951-952, Dees,R.H., 2004